Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

259 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunometabolic Signatures Predict Risk of Progression to Active Tuberculosis and Disease Outcome.
Duffy FJ, Weiner J 3rd, Hansen S, Tabb DL, Suliman S, Thompson E, Maertzdorf J, Shankar S, Tromp G, Parida S, Dover D, Axthelm MK, Sutherland JS, Dockrell HM, Ottenhoff THM, Scriba TJ, Picker LJ, Walzl G, Kaufmann SHE, Zak DE; GC6-74 Consortium. Duffy FJ, et al. Among authors: scriba tj. Front Immunol. 2019 Mar 22;10:527. doi: 10.3389/fimmu.2019.00527. eCollection 2019. Front Immunol. 2019. PMID: 30967866 Free PMC article.
A comparison of IFNgamma detection methods used in tuberculosis vaccine trials.
Beveridge NE, Fletcher HA, Hughes J, Pathan AA, Scriba TJ, Minassian A, Sander CR, Whelan KT, Dockrell HM, Hill AV, Hanekom WA, McShane H. Beveridge NE, et al. Among authors: scriba tj. Tuberculosis (Edinb). 2008 Nov;88(6):631-40. doi: 10.1016/j.tube.2008.06.005. Epub 2008 Sep 17. Tuberculosis (Edinb). 2008. PMID: 18801705 Clinical Trial.
Higher human CD4 T cell response to novel Mycobacterium tuberculosis latency associated antigens Rv2660 and Rv2659 in latent infection compared with tuberculosis disease.
Govender L, Abel B, Hughes EJ, Scriba TJ, Kagina BM, de Kock M, Walzl G, Black G, Rosenkrands I, Hussey GD, Mahomed H, Andersen P, Hanekom WA. Govender L, et al. Among authors: scriba tj. Vaccine. 2010 Dec 10;29(1):51-7. doi: 10.1016/j.vaccine.2010.10.022. Epub 2010 Oct 23. Vaccine. 2010. PMID: 20974305 Free PMC article.
Immunological biomarkers of tuberculosis.
Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Walzl G, et al. Among authors: scriba tj. Nat Rev Immunol. 2011 May;11(5):343-54. doi: 10.1038/nri2960. Epub 2011 Apr 8. Nat Rev Immunol. 2011. PMID: 21475309 Review.
Predominance of interleukin-22 over interleukin-17 at the site of disease in human tuberculosis.
Matthews K, Wilkinson KA, Kalsdorf B, Roberts T, Diacon A, Walzl G, Wolske J, Ntsekhe M, Syed F, Russell J, Mayosi BM, Dawson R, Dheda K, Wilkinson RJ, Hanekom WA, Scriba TJ. Matthews K, et al. Among authors: scriba tj. Tuberculosis (Edinb). 2011 Nov;91(6):587-93. doi: 10.1016/j.tube.2011.06.009. Epub 2011 Jul 20. Tuberculosis (Edinb). 2011. PMID: 21767990 Free PMC article.
Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.
Sutherland JS, Lalor MK, Black GF, Ambrose LR, Loxton AG, Chegou NN, Kassa D, Mihret A, Howe R, Mayanja-Kizza H, Gomez MP, Donkor S, Franken K, Hanekom W, Klein MR, Parida SK, Boom WH, Thiel BA, Crampin AC, Ota M, Walzl G, Ottenhoff TH, Dockrell HM, Kaufmann SH; GCGH Biomarkers for TB consortium. Sutherland JS, et al. PLoS One. 2013 Sep 10;8(9):e74080. doi: 10.1371/journal.pone.0074080. eCollection 2013. PLoS One. 2013. PMID: 24040170 Free PMC article.
259 results